Globus Medical Reports Second Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Globus Medical (GMED) PT Raised to $65 at Needham & Company
August 2, 2018 8:15 AM EDTNeedham & Company raised its price target on Globus Medical (NYSE: GMED) to $65.00 (from $58.00) while maintaining a Buy rating following 2Q earnings report. Revenue was $173M vs. consensus of $168M and non-GAAP EPS was $0.44 vs. consensus of $0.35.
For 2018, GMED raised its revenue... More
Globus Medical (GMED) Tops Q2 EPS by 9c
August 1, 2018 4:59 PM EDTGlobus Medical (NYSE: GMED) reported Q2 EPS of $0.44, $0.09 better than the analyst estimate of $0.35. Revenue for the quarter came in at $173.4 million versus the consensus estimate of $168.03 million.
GUIDANCE:
Globus Medical sees FY2018 EPS of $1.55, versus the consensus of $1.52. Globus... More
